By Leigh Kamping-Carder ( July 22, 2010, 7:34 PM EDT) -- The Federal Trade Commission argued Thursday that it did nothing wrong in its antitrust investigation of a patent settlement between Watson Pharmaceuticals Inc. and Cephalon Inc., in a suit seeking to force Watson CEO Paul M. Bisaro to testify in the probe....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.